|
1. Accepted major perpetrators |
2. Rejected perpetrators |
3. Unclassifiable |
4. Full table |
phenylpropanolamine is not available in Australia/New Zealand, despite evidence suggesting that it may perturb the activities of CYP1A2.
phenylpropanolamine
| CYP1A2 | |
|---|---|
| Not available in Australia or New Zealand | armodafinil artemisinin clinafloxacin enoxacin etintidine furafylline idrocilamide methylcholanthrene mibefradil nafcillin oltipraz perfloxacin phenylpropanolamine pipemidic acid rofecoxib stiripentol thiabendazole troleandomycin zileuton |
Footnotes and References
Disclaimer
WARNING: While all efforts were put in to maintain the accuracy and currency of the information, it is possible that the knowledge and electronic tools may contain errors and inadequacy.
Both Flinder's University and University of New South Wales are not liable to any damages or losses resulted from such circumstances. Clinical discretions are strongly advised at all times.